In situ Vaccination by Direct Dendritic Cell Inoculation: The Coming of Age of an Old Idea?
For more than 25 years, dendritic cell (DC) based vaccination has flashily held promises to represent a therapeutic approach for cancer treatment. While the vast majority of studies has focused on the use of antigen loaded DC, the intratumoral delivery of unloaded DC aiming at in situ vaccination ha...
Main Authors: | Luciano Castiello, Eleonora Aricò, Giuseppina D'Agostino, Laura Santodonato, Filippo Belardelli |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.02303/full |
Similar Items
-
Can Dendritic Cell Vaccination Prevent Leukemia Relapse?
by: Liam J. O’Brien, et al.
Published: (2019-06-01) -
CD209/CD14+ Dendritic Cells Characterization in Rheumatoid and Psoriatic Arthritis Patients: Activation, Synovial Infiltration, and Therapeutic Targeting
by: Viviana Marzaioli, et al.
Published: (2022-01-01) -
Human Dendritic Cells: Their Heterogeneity and Clinical Application Potential in Cancer Immunotherapy
by: Thiago A. Patente, et al.
Published: (2019-01-01) -
Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies
by: Christian H. K. Lehmann, et al.
Published: (2016-03-01) -
A Single-Stranded Oligonucleotide Inhibits Toll-Like Receptor 3 Activation and Reduces Influenza A (H1N1) Infection
by: Candice Poux, et al.
Published: (2019-09-01)